| Entry |
|
|---|
| Name |
Flezurafenib (USAN/INN) |
|---|
| Formula |
C26H21FN4O3
|
|---|
| Exact mass |
456.1598
|
|---|
| Mol weight |
456.47
|
|---|
| Structure |
|
|---|
| Efficacy |
Antineoplastic, pan-RAF inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
BRAF
D13132 Flezurafenib (USAN/INN)
RAF1
D13132 Flezurafenib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 34
1 C8y C 25.6900 -31.0100
2 O2a O 26.8800 -31.7100
3 C8y C 28.0700 -31.0100
4 C8y C 29.2600 -31.7100
5 C8y C 30.5200 -31.0100
6 N5x N 30.5200 -29.6100
7 C8x C 29.3300 -28.9100
8 C8x C 28.0700 -29.6100
9 C1x C 29.2600 -33.1100
10 C1x C 30.5200 -33.8100
11 C5x C 31.7100 -33.1100
12 N1x N 31.7100 -31.7100
13 O5x O 32.9000 -33.8100
14 C8x C 25.6900 -29.6100
15 C8x C 24.5000 -28.9100
16 C8y C 23.2400 -29.6100
17 C8y C 23.2400 -31.0100
18 C8x C 24.5000 -31.7100
19 O2x O 22.0500 -28.9100
20 C1x C 20.8600 -29.6100
21 C1y C 20.8600 -31.0100
22 C1x C 22.0500 -31.7100
23 C8y C 19.6700 -31.7100
24 N4x N 18.5088 -30.9730
25 C8x C 17.4354 -31.8067
26 C8y C 17.9173 -33.0620
27 N5x N 19.2453 -33.0440
28 C8y C 17.1431 -34.2047
29 C8x C 15.7500 -34.2354
30 C8x C 15.0763 -35.4626
31 C8y C 15.8022 -36.6597
32 C8x C 17.1930 -36.6997
33 C8x C 17.8668 -35.4025
34 X F 15.0935 -37.8768
BOND 39
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 3 8 1
9 4 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 5 12 1
14 11 13 2
15 1 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 1 18 1
21 16 19 1
22 19 20 1
23 20 21 1
24 21 22 1
25 17 22 1
26 21 23 1 #Up
27 23 24 1
28 24 25 1
29 25 26 2
30 26 27 1
31 23 27 2
32 26 28 1
33 28 29 2
34 29 30 1
35 30 31 2
36 31 32 1
37 32 33 2
38 28 33 1
39 31 34 1
|
|---|
